Academia Sinica

National Taiwan Ocean University

Other

Gold Nanotech, Inc.

Chien-lung Chen

Medgaea Life Sciences Ltd.

Medgaea Japan Co., Ltd.

Chang-Jer Wu

Jyh-Yih Chen

Han-Ning Huang

Chien-Lung Chen

Cheng-Hsien Chen

Shan-Wen Tan

Ming-Kung Yeh

Masahiko Iha

Dar-Shih Hsieh

Makoto Tomori

Chih-Chun Hong

Yuh-Ting Huang

Bo-Rui Chen

A carbohydrate composition includes fucose, glucuronic acid, galactose, and arabinose. Based on the total weight of the carbohydrate composition, the content of fucose is 45.5% to 76% by weight; the content of glucuronic acid is 11% to 19% by weight; the content of galactose is 4.5% to 14.5% by weight, and the content of arabinose is 5.5% to 18% by weight. A pharmaceutical ingredient including the above-mentioned carbohydrate composition is provided.

Carbohydrate composition as pharmaceutical ingredient and use thereof

A method for enhancing wound healing or treating methicillin-resistant(MRSA) infection in a wound comprising administering a subject in need thereof with a therapeutically effective amount of a tilapia piscidin (TP) is described, wherein the TP is preferably TP3 or TP4.

Tilapia piscidins for use in enhancement of wound healing

The preset invention relates to a new method or composition for treating a gastric ulcer, preventing or treating an infection of, particularly multidrug resistant, using an antimicrobial peptide, a functional derivate, fragment or variant thereof, wherein the antimicrobial peptide is selected from the group consisting of Epi-1, TPs and combination thereof.

Method for treatment of gastric ulcers

The preset invention relates to a new method for wound healing, particularly in burns, comprising Epinecidin-1 (Epi-1) or Pardaxin (GE33), optionally in the incorporation into collagen.

Composition for use in wound healing in burns

A transportation device, transporting a material to a target, includes an input module, a transmission module and an output module. The input module has a containing unit and at least one filter. The at least one filter is connected to the containing unit, and a carrier fluid and the material are stored in the containing unit. The transmission module is coupled to the at least one filter of the input module. The output module has a guiding unit, a throat portion, a first opening and a second opening. The throat portion is positioned between the first opening and the second opening. One end of the guiding unit is connected to the transmission module. The other end of the guiding unit has a guiding corner for connecting to the first opening. The material will enter the output module through the first opening and reaches the target through the second opening.

Transportation device

The present invention discloses a physical nano-complex for preventing and treating cancer and a method for manufacturing the same. The composition contains EGCG and nanogold, wherein the ratio of the EGCG to the nanogold is in a range from 23:0.5&#x2dc;23:10 (ppm/ppm). The present invention further discloses a method for manufacturing the composition, wherein the method is to mix the EGCG and the nanogold sufficiently by an ultrasonication process, which makes the EGCG and the nanogold combine to each other well.

Physical nano-complexes for preventing and treating cancer and method for manufacturing the same

A transportation device, physically transporting material to a target, includes an input module, a transporting module and an output module. The input module provides a carrier fluid. The transporting module is coupled to the input module for receiving the carrier fluid in order to disperse/atomize the material. The material enters the input module through a first opening and reaches the target Through a second opening. The input module further includes a guiding unit having a length longer than or equal to the distance between the throat portion and the second opening. One end of the guiding unit connects the transporting module. The other end of the guiding unit has a guiding comer for connecting to the first opening.

A method of enhancing a mammalian immune response to a virus is disclosed. The method comprises administering a composition comprising an effective amount of epinecidin (Epi)-1 and the virus to a mammal, wherein the virus has envelope protein and is infectious to the mammal. A vaccine kit and a method for preventing Japanese encephalitis virus (JEV) infection are also disclosed.

Growing community of inventors

Taipei, Taiwan

Chang-Jer Wu